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ABSTRACT
Objective: Ex vivo and in vitro cell cultures require a basal medium with added supplements containing growth factors, proteins, and enzymes to 
support attachment, growth, and proliferation. Fetal bovine serum (FBS) is used to supplement cell culture media. However, human platelet lysate 
(hPL) represents an attractive alternative as it is nonxenogeneic.
Methods: Human third molars were collected from six healthy donors (19–35 years old) with no history of regular alcohol consumption or smoking. 
Human dental pulp stem cells (hDPSCs) at the second passage were divided into two culture media groups, 10% FBS and 5% hPL, as well as a control 
group after 24 h of serum starvation. A flow cytometry analysis was conducted to measure CD90, CD105, CD73, CD34, CD45, and Human Leukocyte 
Antigen-DR isotype (HLA-DR). Cellular proliferation was evaluated on days 1, 3, and 5.
Results: The flow cytometry analysis revealed that the majority of the cells expressed positive mesenchymal stem cell surface markers, including 
CD73 (98.5%), CD90 (98.3%), and CD105 (71.0%), and lacked CD34, CD45, and HLA-DR. There were significant differences among the 5% hPL, 10% 
FBS, and control groups on days 1, 3, and 5.
Conclusion: For a nonxenogeneic culture, 5% hPL can be used as an alternative in culture media for hDPSC proliferation.
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INTRODUCTION
Immature teeth are at risk for developing pulpal necrosis due to 
trauma, caries, and anatomical variations[1]. Routine root canal 
treatment protocols to clean and obturate these teeth cannot be 
adequately performed on immature roots [2]. As an alternative 
technique, regenerative endodontic procedures are intended to 
promote tooth survival and function [1]. The American Association of 
Endodontists adopted the term “regenerative endodontics” in 2007 on 
the basis of a tissue engineering concept [3]. Nakashima described the 
three essential components of tissue engineering: Stem cells, bioactive 
growth factors, and biomimetic three-dimensional scaffolds [3-5]. 
These three components play an essential roles in the restoration of 
previously damaged structures [4].
Human dental pulp stem cells (hDPSCs) are a unique type of 
mesenchymal stem cells (MSCs) that are present in the cell-rich zone 
and core of the dental pulp. On isolation and culture in a high-serum 
medium, rapidly proliferating hDPSCs are capable of differentiating 
into mesenchymal-derived odontoblasts, osteoblasts, adipocytes, 
and chondrocytes, depending on the type of regulatory molecules 
present [6,7].
Ex vivo and in vitro cell cultures require a basal medium [8]. The 
compositions of cell culture media still closely resemble formulas 
that were developed in the pioneering work of the 1950s. Harry 
Eagle described basal media as a mixture of 29 essential components, 
including 13 amino acids, 9 vitamins, 1 D-glucose, and 6 inorganic 
salts [9]. In the early days of cell culture, this type of basal medium 
required supplements, including growth factors, proteins, and enzymes, 
to support attachment, growth, and proliferation [8,9]. In most clinical 
trials, including the first hDPSC transplantation, fetal bovine serum 
(FBS) has been used as the main nutritional supplement [8,9]. FBS 
is used to supplement cell culture media, because the fetal milieu is 
enriched in growth factors, compared with that from mature animals, 
and has a low concentration of antibodies. In contrast to plasma, serum 
contains a variety of growth factors, cytokines, and chemokines derived 
during blood coagulation [10].
FBS creates an obstacle for use in clinical trials as it carries a risk of the 
proteins initiating a xenogeneic response, protracted expansion times, 
exposure to zoonosis, and allergic side effects [6,11]. Recently, several 
groups have demonstrated that human platelet lysate (hPL) represents 
an attractive alternative to FBS that permits the scale-up of MSCs [6]. 
hPL is generated by subjecting common platelet units to several freeze-
thaw cycles that damage the platelet membranes and release growth 
factors into the plasma [6]. Therefore, hPL can replace FBS in many 
cell culture systems that have previously been solely dependent on 
the presence of FBS [8]. Griffiths et al. stated that 5% hPL accelerates 
cellular proliferation and produces smaller cell size on the proliferation 
of bone marrow stromal cells [12].
Recently, hPL has been commercially produced. UltraGROTM® is a 
commercially manufactured hPL that requires heparin to activate 
growth factors [13]. Existing research on this product has been focused 
on the proliferation of bone marrow stromal cells, so further research 
is required to determine its effect on the proliferation of hDPSCs, 
especially in the early phase cell cycles because the G0, G1, and S phases 
determine cellular proliferation and its proportion during the first 
3 days. In these phases, growth factors play a role in proliferation [14].
METHODS
This study was approved by the Ethics Committee of the Faculty of 
Dentistry, Universitas Indonesia (no. 133/ethical approval/FKGUI/
XII/2017, no. Protocol: 051331017). Six human third molars were 
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collected at Oral Surgery Department, Faculty of Dentistry, Universitas 
Indonesia, from 19 to 35-year-old healthy donors with no history of 
alcohol or smoking. Teeth were transferred to the cell culture laboratory 
where stem cells from the pulp tissues were isolated. Briefly, the 
tooth was cut around the cementoenamel junction, and then the pulp 
tissue was gently removed from the chambers, sliced into 0.5–1.0 mm 
sections, and diluted in an enzyme solution that consisted of 3.0 mg/mL 
collagenase type I and 4.0 mg/mL dispase (Sigma-Aldrich, St. Louis, 
MO, USA) for 30–60 min at 37°C. The mixture was cultured in 3 mL 
of Dulbecco’s Modified Eagle’s Medium supplemented with 10% FBS 
(HyClone), 100 U/mL penicillin G (Roche, Basel, Switzerland), and 100 
mg/mL streptomycin (Roche) and incubated in an atmosphere of 5% 
CO2 at 37°C.
When the cells reached 80% confluency, single cell clones were isolated 
by limiting the dilution. The cells used in this study were in the second 
or third passage. hDPSCs at the second passage were divided into two 
culture media groups, 10% FBS and 5% hPL, as well as a control group 
after 24 h of serum starvation, with each group containing six biological 
replicates. Serum starvation procedures were performed according to a 
previously published method [15]. The hPL culture media used in this 
study consisted of 5% hPL from a commercial product culture medium 
(Helios UltraGRO). The preparation of this product was carried out as 
per the manufacturer’s instructions.
A flow cytometry analysis was conducted using FACSVerse (BD 
Biosciences), and data were analyzed using FlowJo software. The tested 
markers included CD90, CD105, and CD73 as a positive cocktail of MSCs 
and CD34, CD45, and Human Leukocyte Antigen-DR isotype (HLA-
DR) as a negative cocktail. During days 1, 3, and 5, the proliferation 
of hDPSCs was evaluated using a 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide assay according to the manufacturer’s 
instructions. Data analysis for the potential ability of each group 
was analyzed using one-way analysis of variance (ANOVA) or Mann–
Whitney U-test, and differences between days 1, 3, and 5 were analyzed 
using the one-way ANOVA, Kruskal–Wallis or Friedman test.
RESULTS
Flow cytometry revealed that the majority of cells expressed hDPSC 
positive surface markers, including CD73 (98.5%), CD90 (98.3%), and 
CD105 (71.0%), and were negative for CD34, CD45, and HLA-DR Fig. 1. 
The result of statistical analysis hDPSCs proliferation consists of three 
different growth media groups; the control group was cells after 24 h 
of serum starvation with 1% FBS, 10% FBS group, and 5% hPL group.
The statistical results of the mean value of proliferation in hDPSCs on 
the day 1 showed that 5% hPL proved to have the ability to initiate 
proliferation in hDPSCs as well as 10% FBS Table 1. The highest 
proliferation rate of hDPSCs in this study was with 10% FBS (2381.70) 
on day 5 and 5% hPL (111.16) on day 3 Table 2 and 3. The proliferation 
of hDPSCs between the three groups was significantly different on days 
1, 3, and 5 Table 4 and 5.
DISCUSSION
This study highlights hPL as a replacement for FBS in culture media for 
the proliferation of hDPSCs [16]. hDPSCs were first isolated from teeth 
in 2000 by Gronthos et al. and are considered a primary source of MSCs. 
MSCs are multipotent progenitors that can differentiate into multiple 
cell lineages, such as osteoblasts, adipocytes, and chondrocytes. MSCs 
are currently expanded in vitro, either under experimental or under 
clinical-grade conditions in the presence of 10–20% FBS, which is 
considered crucial for the in vitro expansion of MSCs [7,9].
The possibility of using animal-free culture media has been reported 
in several recent studies by substituting FBS with human-derived 
supplements such as hPL or human serum [7,16]. Media preparations 
have already been demonstrated to be a powerful source of growth factors, 
useful in the treatment of a variety of soft and hard tissue conditions [7].
We tested two different supplement culture media for hDPSCs, that is, 
10% FBS and 5% hPL, at 3 evaluation times (days 1, 3, and 5). Our data 
Table 1: The mean analysis of hDPSCs proliferation in three 
different growth media groups on day 1
Groups n Mean SD p
Control 6 7.88 0.29 0.001*
10% FBS 6 229.36 6.09
5% hPL 6 78.15 2.87
*ANOVA test, p<0.05. FBS: Fetal bovine serum, hpL: Human platelet lysate, 
hDPSCs: Human dental pulp stem cells
Table 2: The mean analysis of hDPSCs proliferation in three 
different growth media groups on day 3
Groups n Median Max ‑ Min p
Control 6 8.55 8.30–11.20 0.001*
10% FBS 6 2199.04 531.40–3144.58
5% hPL 6 11.16 101.85–140.20
*Kruskal–Wallis test, p<0.05. FBS: Fetal bovine serum, hpL: Human platelet 
lysate, hDPSCs: Human dental pulp stem cells
Table 3: The mean analysis of hDPSCs proliferation in three 
different growth media groups on day 5
Groups n Median Max‑Min p
Control 6 10 9.10–14.70 0.001*
10% FBS 6 2381.70 448.51–367.63
5% hPL 6 18.79 14.63–104.43
*Kruskal–Wallis test, p<0.05. FBS: Fetal bovine serum, hpL: Human platelet 
lysate, hDPSCs: Human dental pulp stem cells
Table 4: The difference of hDPSCs proliferation between three 
different growth media groups on 3 times observations






Control versus 10% FBS 0.001* 0.004* 0.004*
Control versus 5% hPL 0.001* 0.004* 0.010*
10% FBS versus 5% hPL 0.001* 0.004* 0.004*
*Tamhane test, p<0.05; Mann–Whitney U-test, p<0.05. FBS: Fetal bovine serum, 
hpL: human platelet lysate, hDPSCs: Human dental pulp stem cells
Table 5: The analysis of hDPSCs proliferation in three different growth media groups on 3 times observations
Groups Proliferation of hDPSCs at 3 times observations (%) p‑value
1 Day mean±SD 3 Days median (Min‑Max) 5 Days median (Min‑Max)
Control 7.88±0.29 8.55 (8.30–11.20) 10 (9.10–14.70) 0.002*
10% FBS 229.36±6.09 2199.04 (531.40–3144.58) 2381.70 (448.51–367.63) 0.009*
5% hPL 78.15±2.87 111.16 (101.85−140.20) 18.79 (14.63–104.43) 0.135
*Friedman test, p<0.05. FBS: Fetal bovine serum, hpL: human platelet lysate, hDPSCs: Human dental pulp stem cells
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demonstrated that 10% FBS is superior to 5% hPL in terms of potential 
proliferative ability. This result is in accordance with a previous study by 
Ma et al. that compared FBS with 1% and 2% hPL, where hPL showed a 
higher proliferation rate during the 1st days of culture, whereas 5% hPL 
never surpassed FBS [17]. On the contrary, Masuki et al. concluded that 
5% hPL had a significantly higher proliferation rate when compared with 
10% FBS [18]. The variability in hPL manufacturing influences the content 
of the primary growth factors that result in cell proliferation [17,18]. hPL 
contains a pool of endogenous growth factors, such as TGF-β, PDGF, FGF, 
and IGF. These growth factors have been shown to enhance MSC expansion 
under in vitro conditions, but it should be noted that the level of growth 
factors varies considerably between species and donors [6].
We observed a decrease in the proliferation of hDPSCs with 5% hPL 
after days 3. This result met our expectations, as explained in a study 
by Saeed et al., who showed that the proliferation of hDPSCs at the 
1st day and had an inhibitory growth pattern on day 3 and after [11]. 
Furthermore, the G0 phase of the cell cycle requires growth factors to 
allow the cell to enter the cycle while preparing for DNA synthesis. The 
G1 phase determines the development of cell shape and size. The G0, 
G1, and S phases determine cellular proliferation and its proportion 
during the first 3 days. In these phases, growth factors play a role in 
proliferation [14].
In this study, we aimed to analyze the proliferation of hDPSCs in 10% 
FBS compared with 5% hPL as an alternative culture medium. The 
mean proliferation on day 1 showed that 5% hPL could initiate the 
proliferation of hDPSCs as well as 10% FBS. The overgrowth cells on 
10% FBS may indicate that the proliferation was not in the proper cell 
cycle, but this result still needs further confirmation. Moreover, hPL can 
be considered as an alternative for cell-based therapies, such as tissue 
engineering and regenerative approaches.
CONCLUSION
It can be concluded that 5% hPL has the capacity for hDPSC proliferation 
as well as 10% FBS on day 1 due to the high concentration of natural 
growth factors contained in hPL. Therefore, hPL can be considered 
an alternative culture media supplement for hDPSCs but in limited 
observation time. Further research using other type of platelet culture 
media still need to be conducted.
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Fig. 1: Flow cytometry of human dental pulp stem cell
